
GNQ Insilico Targets Faster Adoption of Precision Medicine and Clinical AI in Drug Development
GNQ Insilico and IBM unite to transform drug development and patient care through digital twin intelligence GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, has announced a strategic collaboration with IBM aimed at accelerating the adoption of personalized, data-driven…










